Drug Interactions for Patients with Respiratory Diseases Receiving COVID-19 Emerged Treatments.

ABSTRACT: Pandemic of coronavirus disease (COVID-19) is still pressing the healthcare systems worldwide. Thus far, the lack of available COVID-19-targeted treatments has led scientists to look through drug repositioning practices and exploitation of available scientific evidence for potential efficient drugs that may block biological pathways of SARS-CoV-2. Till today, several molecules have emerged as promising pharmacological agents, and more than a few medication protocols are applied during hospitalization. On the other hand, given the criticality of the disease, it is important for healthcare providers, especially those in COVID-19 clinics (i.e., nursing personnel and treating physicians), to recognize potential drug interactions that may lead to adverse drug reactions that may negatively impac

SUBMITTER: Spanakis M 

PROVIDER: S-EPMC8583457 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature